A stakeholder meeting was held on 4 February 2015 to discuss issues related to a recent submission to the PBAC to list nitisinone (Orfadin) on the PBS for the treatment of tyrosinaemia type 1.

For more details, go to: http://www.pbs.gov.au/industry/listing/elements/pbac-meetings/pbac-stakeholder-meetings/nitisinone-stakeholder-meeting-outcome-statement-feb-2015.pdf